Hsbc Holdings PLC Takes $1.85 Million Position in Pediatrix Medical Group, Inc. $MD

Hsbc Holdings PLC bought a new position in Pediatrix Medical Group, Inc. (NYSE:MD) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 73,605 shares of the company’s stock, valued at approximately $1,854,000. Hsbc Holdings PLC owned about 0.09% of Pediatrix Medical Group at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. BlackRock Inc. bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at $347,383,000. Dimensional Fund Advisors LP grew its holdings in Pediatrix Medical Group by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock valued at $82,496,000 after buying an additional 287,696 shares in the last quarter. Wasatch Advisors LP increased its position in shares of Pediatrix Medical Group by 21.9% during the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock valued at $63,297,000 after buying an additional 448,360 shares during the period. Geode Capital Management LLC increased its position in shares of Pediatrix Medical Group by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 2,181,712 shares of the company’s stock valued at $46,674,000 after buying an additional 14,421 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Pediatrix Medical Group by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,552,585 shares of the company’s stock worth $33,210,000 after buying an additional 105,345 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Up 0.2%

Shares of MD opened at $26.66 on Monday. Pediatrix Medical Group, Inc. has a 1 year low of $15.69 and a 1 year high of $27.94. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a 50 day simple moving average of $26.06 and a two-hundred day simple moving average of $23.19. The firm has a market cap of $2.17 billion, a P/E ratio of 12.76 and a beta of 0.66.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The firm had revenue of $487.78 million for the quarter, compared to the consensus estimate of $478.49 million. During the same period last year, the firm posted $0.53 earnings per share. The business’s revenue was up 4.1% compared to the same quarter last year. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their price target for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. UBS Group lifted their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Finally, Truist Financial boosted their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Seven equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus target price of $25.00.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.